Pharmacytimes: Condition Center: HIV HIV en-us Mon, 27 Mar 2017 02:30:05 UTC Mon, 27 Mar 2017 02:30:05 UTC Veterans Evaluate VA Mail-Order System for HIV Care The US Veterans Administration (VA) health care system is the largest in the United States, serving 22 million former military members.&nbsp; 10:00 AM, Wed March 22, 2017 Is Dolutegravir Monotherapy Effective in Treating HIV? Although dolutegravir (DTG) is known for its high genetic barrier to resistance, its durability to maintain virologic suppression had not previously been evaluated. 9:34 PM, Sun March 19, 2017 Achieving Sustained HIV remission with Alpha-4-beta-7 Monoclonal Antibodies An integrin is a receptor protein attached to cells that aid in allowing the cell to react to the extracellular matrix. 9:10 PM, Mon March 13, 2017 HIV and Tuberculosis Co-infection: Treat Early Tuberculosis (TB) and HIV are 2 of the deadliest diseases worldwide, with TB recently reaching the top of the list in 2014.&nbsp; 10:00 AM, Mon March 13, 2017 Seborrheic Dermatitis and HIV: Common, Severe Among the general population, roughly 5% of people develop seborrheic dermatitis. However, seborrheic dermatitis affects 85-95% of patients with HIV.<br /> &nbsp; 9:17 AM, Tue March 7, 2017 Novel Technique Halves HIV Drug Dosage A novel nanotechnology approach can reduce HIV treatment dosages and improve drug delivery, according to a study. 9:18 AM, Mon March 6, 2017 HIV/HCV Coinfection: Sustained Viral Response Possible and Likely Up to 30% of &nbsp;people who have HIV, and more than 80% of HIV-positive injection drug users also have hepatitis C virus (HCV) as well.&nbsp; 7:00 AM, Wed March 1, 2017 HIV PrEP: Increasing Willingness and Intent to Engage A team of researchers from the City University of New York found fewer than 1 in 10 suitable PrEP candidates are currently taking PrEP, in a new article published in <em>Journal of Acquired Immune Deficiency Syndrome</em>. 9:48 AM, Mon February 20, 2017 CROI 2017: Daily Oral PrEP Effective Even in Presence of Bacterial Vaginosis Women with abnormal vaginal microbiota showed no difference in efficacy of daily oral PrEP compared to women with normal vaginal microbiota, according to data presented at the annual Conference on Retroviruses and Opportunistic Infections in Seattle.&nbsp; 12:46 PM, Thu February 16, 2017 CROI 2017: Positive Results Reported for Two-drug HIV Regimen The program&nbsp;comprises 2&nbsp;studies with over 1000 patients who previously achieved viral suppression on a 3- or 4-drug antiretroviral regimen.&nbsp; 9:34 PM, Wed February 15, 2017 Effects of Recreational Drug Use in Patients Taking HAART Recreational drug use has been established as a risk factor for HIV acquisition, and many patients will find lifestyle modification&mdash;eschewing recreational drug use&mdash;difficult.&nbsp; 9:06 AM, Tue February 7, 2017 CDC: Improved HIV Care Needed for African Americans February 7 marks National Black HIV/AIDS Awareness Day, which promotes awareness of HIV and AIDS and the disparity in care between African Americans in the United States compared to individuals of different races.&nbsp;<br /> &nbsp; 9:33 AM, Mon February 6, 2017 Is HIV A Risk Factor for Diabetes? Adults who have HIV are more likely to develop diabetes than the general population, a study published in <em>BMJ Open Diabetes Research &amp; Care</em> estimates.&nbsp; 8:30 AM, Thu February 2, 2017 Misconceptions About Nicotine Among People Living with HIV Researchers at Johns Hopkins University investigated knowledge of smoking and nicotine among HIV-positive smokers in a study published online in <em>Addictive Behaviors</em>.&nbsp; 11:43 AM, Thu January 26, 2017 HIV Neutralizing Antibody Showing Promise in Clinical Trial 10-1074 was well-tolerated, demonstrated favorable pharmacokinetic properties, and had high antiviral activity among patients with HIV, a recent study found.&nbsp; 12:13 PM, Tue January 24, 2017 Study Notes Missed Opportunity for HIV Detection A new study, published in <em>Psychiatric Services,</em> reveals a missed opportunity for early HIV detection and treatment.&nbsp; 9:44 AM, Tue January 24, 2017 ART in HIV: Start Today In HIV treatment, national and global guidelines recommend initiating antiretroviral therapy (ART) in all patients, regardless of CD4 count.&nbsp; 2:29 PM, Tue January 10, 2017 Statin Use in HIV: Check Vitamin D Levels A study published in a recent issue of the <em>Journal of Acquired Immune Deficiency Syndromes</em> demonstrates that low baseline vitamin D deficiency may decrease the effectiveness of rosuvastatin in adults with HIV.<br /> &nbsp; 2:08 PM, Mon January 9, 2017 Counsel PrEP and ART Strategies in HIV-Serodiscordant Couples Experts agree that integrated antiretroviral therapy (ART) for HIV-positive partners and time-limited pre-exposure prophylaxis (PrEP) for negative partners almost eliminates HIV transmission.&nbsp; 11:43 AM, Thu December 29, 2016 Studies in Virology Every Pharmacist Should Know Over the years, a number of landmark clinical studies in virology have been published, shaping how we treat the disease today. 10:35 PM, Tue December 27, 2016